Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Open in API
Filings indexed 1,611 across all filing types
Latest filing 2022-03-14 Director's Dealing
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
111年02月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders and related parties of the company 杏輝藥品工業股份有限公司. It lists the number of shares held by directors, senior management, and other insiders, including pledged shares and shares held by spouses or minors. The document is focused on insider shareholdings and does not contain financial statements, earnings data, or management discussion. It is not a report of a meeting, nor an announcement of voting results or dividends. The content aligns with disclosures related to insider share transactions or holdings. Given the nature of the data, this document fits best under the category of Director's Dealing (DIRS), which covers reports of personal share transactions or holdings by company directors and executives. The document length is 3408 characters, which is consistent with a detailed insider shareholding report rather than a full financial report or announcement. Therefore, the classification is DIRS with high confidence.
2022-03-14 Chinese
111年2月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 杏輝, providing information on loan balances and endorsement guarantees for the current and previous months. It contains tabulated financial data but is very short (624 characters) and does not include comprehensive financial statements or detailed analysis. There is no indication of it being an annual or interim report, audit report, or any other detailed filing. It appears to be a regulatory disclosure of specific financial information, likely a routine regulatory announcement. Given the short length and nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2022-03-09 Chinese
111年2月營業收入
Fund Information / Factsheet Classification · 85% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 杏輝, with comparisons to the previous year. It includes financial data for a specific month (February of 民國111年, which corresponds to 2022) and cumulative year-to-date figures. The document is short (770 characters) and primarily presents financial summary data without detailed financial statements or management discussion. It does not appear to be a full annual or interim report, nor an earnings release with highlights. It is more of a brief financial summary or factsheet. Given the concise nature and summary format, the best fitting category is Fund Information / Factsheet (FS).
2022-03-09 Chinese
111年01月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, senior management, and their related parties. It lists share types, quantities held at various times, increases and decreases in holdings, and other related information. The content is focused on insider share transactions and holdings rather than financial results, governance policies, or meeting materials. There is no indication of it being a full financial report, earnings release, or management discussion. The document is not a brief announcement but a detailed disclosure of insider shareholdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is substantial and contains actual data, not just an announcement or certification. Therefore, the appropriate classification is DIRS with high confidence.
2022-02-14 Chinese
111年01月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledged shares by company insiders, including directors, supervisors, and senior management. It lists individual names, titles, share counts, and pledge ratios. There is no indication of financial statements, earnings data, or report publication. The content focuses on insider shareholdings and related disclosures. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions or holdings by company directors and executives. The document length is 3408 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report. Therefore, the appropriate classification is DIRS.
2022-02-14 Chinese
111年1月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (杏輝) providing details about guarantees and endorsements, including amounts and limits, for the current and previous months. It contains tabulated financial data but is very short (624 characters) and does not present a comprehensive financial report or analysis. It appears to be a regulatory disclosure related to financial guarantees rather than a full report like an Annual Report or Interim Report. Given the nature and length, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2022-02-11 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.